Molecular You, the Vancouver-based data-driven health intelligence company, announced the signing of a Master Services Agreement with Hoffmann-La Roche Limited (Roche Canada). This agreement enables Roche to use Molecular You’s comprehensive molecular profiling technology.“We are very proud of this agreement with Roche,” said Molecular You president, CEO and co-founder Rob Fraser, “as Roche shares our vision to provide patient-centred and evidence-based care. Together, our world-leading teams and technologies will enable a data-driven care model that treats not just the disease but also the patient suffering from that disease.”“Current medical care often employs a “one-size-fits-all” approach that ignores the fact that we are all very different from one another” notes Molecular You co-founder and board chair Professor Pieter Cullis. The detailed molecular-level profiles prepared by Molecular You provide the insight needed to individualize patient care and practice effective preventive medicine. Dr. Cullis, author of The Personalized Medicine Revolution, adds that “the agreement with Roche provides an important validation of the potential of Molecular You’s technology to improve healthcare.”
